These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18589468)

  • 1. Quantitative interpretation of human biomonitoring data.
    Clewell HJ; Tan YM; Campbell JL; Andersen ME
    Toxicol Appl Pharmacol; 2008 Aug; 231(1):122-33. PubMed ID: 18589468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
    Liao KH; Tan YM; Clewell HJ
    Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
    Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context.
    Hays SM; Aylward LL
    J Appl Toxicol; 2009 May; 29(4):275-88. PubMed ID: 19115313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
    Aylward LL; Kirman CR; Blount BC; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental chemicals in people: challenges in interpreting biomonitoring information.
    LaKind JS; Barraj L; Tran N; Aylward LL
    J Environ Health; 2008 May; 70(9):61-4. PubMed ID: 18517157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
    Boogaard PJ; Hays SM; Aylward LL
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomonitoring equivalents for hexachlorobenzene.
    Aylward LL; Hays SM; Gagné M; Nong A; Krishnan K
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):25-32. PubMed ID: 20547196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making sense of human biomonitoring data: findings and recommendations of a workshop.
    Bahadori T; Phillips RD; Money CD; Quackenboss JJ; Clewell HJ; Bus JS; Robison SH; Humphris CJ; Parekh AA; Osborn K; Kauffman RM
    J Expo Sci Environ Epidemiol; 2007 Jul; 17(4):308-13. PubMed ID: 17495868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human exposure assessment to environmental chemicals using biomonitoring.
    Calafat AM; Ye X; Silva MJ; Kuklenyik Z; Needham LL
    Int J Androl; 2006 Feb; 29(1):166-71; discussion 181-5. PubMed ID: 16466536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human milk biomonitoring data: interpretation and risk assessment issues.
    LaKind JS; Brent RL; Dourson ML; Kacew S; Koren G; Sonawane B; Tarzian AJ; Uhl K
    J Toxicol Environ Health A; 2005 Oct; 68(20):1713-69. PubMed ID: 16176917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpreting human biomonitoring data in a public health risk context using Biomonitoring Equivalents.
    Hays SM; Aylward LL
    Int J Hyg Environ Health; 2012 Feb; 215(2):145-8. PubMed ID: 22192580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomonitoring Equivalents for triclosan.
    Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):10-7. PubMed ID: 20541577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of human biomonitoring (HBM) of chemical exposure in the characterisation of health risks under REACH.
    Boogaard PJ; Aylward LL; Hays SM
    Int J Hyg Environ Health; 2012 Feb; 215(2):238-41. PubMed ID: 22177527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of absorbed dose estimates derived from passive dosimetry measurements to those derived from biological monitoring: validation of exposure monitoring methodologies.
    Ross J; Chester G; Driver J; Lunchick C; Holden L; Rosenheck L; Barnekow D
    J Expo Sci Environ Epidemiol; 2008 Mar; 18(2):211-30. PubMed ID: 17593947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomonitoring Equivalents for bisphenol A (BPA).
    Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):18-24. PubMed ID: 20541576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomonitoring: is body burden relevant to public health?
    Paustenbach D; Galbraith D
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):249-61. PubMed ID: 16473444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.
    Hays SM; Aylward LL; LaKind JS; Bartels MJ; Barton HA; Boogaard PJ; Brunk C; DiZio S; Dourson M; Goldstein DA; Lipscomb J; Kilpatrick ME; Krewski D; Krishnan K; Nordberg M; Okino M; Tan YM; Viau C; Yager JW;
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S4-15. PubMed ID: 18583008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation of Biomonitoring Equivalents for cyfluthrin.
    Hays SM; Aylward LL; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):268-75. PubMed ID: 19751788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.